Literature DB >> 26477469

Advances in Immuno-Oncology: Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer-Introduction.

Mark A Socinski1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26477469     DOI: 10.1053/j.seminoncol.2015.09.018

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  3 in total

1.  Multiparametric MRI for early identification of therapeutic response in recurrent glioblastoma treated with immune checkpoint inhibitors.

Authors:  Joseph Song; Priyanka Kadaba; Amanda Kravitz; Adilia Hormigo; Joshua Friedman; Puneet Belani; Constantinos Hadjipanayis; Benjamin M Ellingson; Kambiz Nael
Journal:  Neuro Oncol       Date:  2020-11-26       Impact factor: 12.300

2.  Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases.

Authors:  Surabhi Ranjan; Martha Quezado; Nancy Garren; Lisa Boris; Christine Siegel; Osorio Lopes Abath Neto; Brett J Theeler; Deric M Park; Edjah Nduom; Kareem A Zaghloul; Mark R Gilbert; Jing Wu
Journal:  BMC Cancer       Date:  2018-03-01       Impact factor: 4.430

Review 3.  Gliomatosis Cerebri: Current Understanding and Controversies.

Authors:  Surabhi Ranjan; Katherine E Warren
Journal:  Front Oncol       Date:  2017-08-07       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.